Go to ...

Nordens Ekonomi Norge

RSS Feed

9. desember 2018

Akcea and Ionis Receive FDA Approval of TEGSEDI™ (inotersen) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults


Euroinvestor.com A/S Euroinvestor.com A/S




TEGSEDI provides powerful knockdown of TTR protein, delivering significant and sustained benefits in neuropathy and quality of life






TEGSEDI is an eff..

More Stories From

Do NOT follow this link or you will be banned from the site!
Read previous post:
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tribune Media Company – TRCO

NEW YORK, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tribune Media...

Close